J&J to purchase heart medical tech firm Abiomed for $17.3b
Johnson & Johnson (J&J), one of the world’s biggest makers of medical devices, said it will purchase Abiomed Inc. for about $17.3 billion, building on its portfolio of technology to assist heart function. J&J will pay $380 a share in cash, according to a statement. That represents a premium of about 50% over Abiomed’s closing price, and is close to ...
Read More »
The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.